Studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9. Kumar M, Singh G, Sharma S, Gupta D, Bansal V, Arora V, Bhat M, Srivastava SK, Sapra S, Kharbanda S, Dinda AK and S. Harpal. Nanoscale. 2014;6(23):14473-83. [Impact Factor 6.75]
Only logged in customers who have purchased this product may leave a review.